MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2021

    White matter and cognition in Parkinson’s disease

    S. Ryman, C. Wertz, K. Poston, N. Shaff, A. Hartman, A. Horner, A. Mayer, A. Vakhtin, A. Deligtisch, S. Pirio Richardson (Albuquerque, USA)

    Objective: Examine whether a recently developed MRI biomarker intended to assess cerebrovascular small vessel disease, peak width of skeletonized mean diffusivity (PSMD)[1], predicts cognitive decline…
  • MDS Virtual Congress 2021

    Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s disease

    D. Pourzinal, J. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (Herston, Australia)

    Objective: We aimed to delineate the dual syndrome subtypes of PD-MCI using a data-driven approach and explore hippocampal functional connectivity of the posterior-cortical syndrome. Background:…
  • MDS Virtual Congress 2021

    Subthalamic nucleus deep brain stimulation implant hemisphere differentially changes verbal fluency in patients with Parkinson disease

    V. Del Bene, D. Marotta, R. Martin, C. Gonzalez, J. Bentley, B. Guthrie, S. Black, M. Nelson, H. Walker (Birmingham, USA)

    Objective: To investigate verbal fluency following unilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in patients with Parkinson’s disease (PD). Background: Verbal fluency declines in…
  • MDS Virtual Congress 2021

    Depression in Patients with Parkinson’s disease among Tomsk population

    M. Nikitina, N. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: To identify clinical predictors of depression in Tomsk PwPD. Background: Depression is often an under-recognized feature of Parkinson's disease (PD). It is important to…
  • MDS Virtual Congress 2021

    Effects of white matter hyperintensities, neuropsychiatric symptoms, and cognition on activities of daily living: Differences between Dementia with Lewy Bodies and Alzheimer’s disease

    S. Mirza, U. Saeed, J. Ramirez, N. Herrmann, S. Black, M. Masellis (Toronto, Canada)

    Objective: To investigate if White matter hyperintensities (WMHs), neuropsychiatric symptoms and cognitive performance associate with, and/or predict activities of daily living (ADLs) differently in Alzheimer’s…
  • MDS Virtual Congress 2021

    Initial longitudinal analyses of objectively assessed cognitive functional abilities in a cohort with Parkinson’s disease

    S. Holden, A. Fought, K. Olson, N. Lopez-Esquibel, T. Carlisle, L. Medina (Aurora, USA)

    Objective: Detect the earliest changes in cognitively demanding activities of daily living in Parkinson's disease (PD) and determine their relationship with changes in global cognition…
  • MDS Virtual Congress 2021

    The Functional Impact of REM Sleep Behavior Disorder in Parkinson’s Disease with Mild Cognitive Impairment

    R. Schade, E. Bayram (La Jolla, USA)

    Objective: This study examines whether severity and the functional impact of cognitive decline in Parkinson’s disease mild cognitive impairment (PD MCI) participants differ between those…
  • MDS Virtual Congress 2021

    Cognition-related functional topographies in Parkinson’s disease: Localized loss of the ventral default mode network

    K. Schindlbeck, A. Vo, P. Mattis, K. Villringer, F. Marzinzik, J. Fiebach, D. Eidelberg (Manhasset, USA)

    Objective: We sought to determine whether functional network abnormalities seen in patients with Parkinson’s disease (PD) and cognitive decline reflect the loss of the default…
  • MDS Virtual Congress 2021

    Combined effects of GBA mutations and STN-DBS negatively impact cognition in Parkinson’s disease

    G. Pal, G. Mangone, E. Hill, V. Lythe, D. Ehrlich, R. Saunders-Pullman, V. Shanker, S. Bressman, R. Alcalay, P. Garcia, K. Marder, J. Aasly, M. Mouradian, B. Ouyang, Y. Liu, S. Ruehl, M. Rosenbaum, S. Anderson, B. Bernard, D. Hall, S. Sani, L. Verhagen, R. Debie, T. Foltynie, J. Corvol, C. Goetz (New Brunswick, USA)

    Objective: To compare the rate of change in cognition between glucocerebrosidase (GBA) mutation carriers and non-carriers with and without subthalamic nucleus deep brain stimulation (STN-DBS)…
  • MDS Virtual Congress 2021

    Morbidity and mortality from neurodegenerative patients hospitalized with COVID-19 in the Chicagoland area

    R. Patel, G. Stebbins, B. Barton (Chicago, USA)

    Objective: To assess morbidity and mortality of acute COVID-19 infection in hospitalized patients with neurodegenerative diseases and compare with age-matched controls. Background: Outcomes from COVID-19…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley